Only variable costs were included in the analysis; fixed costs were not considered. rapid and conventional HIV testing in the following scenarios: (1) sexually transmitted disease (STD) clinic counseling and testing (CT), (2) STD clinic screening, and (3) emergency department (ED) screening. Costs were estimated from the provider perspective in 2006 dollars. A decision analytic model was developed to estimate the cost per HIV-infected patient notified of test results using the two testing procedures in the three scenarios. == Results. == Although the complete rapid testing procedure was more expensive than conventional testing, the cost per HIV-infected patient receiving test results was lower for the rapid test compared with conventional testing in all Cd19 scenarios. Per-patient costs of receiving results were lowest in the ED screening scenario and highest in the STD CT scenario. These costs were sensitive to changes in test costs, HIV prevalence, and return rates following conventional tests. == Conclusion. == HIV screening in general health-care settings is economically feasible, particularly with rapid tests that Irosustat lower the cost of HIV-infected patients receiving their test results. In September 2006, the Centers for Disease Control and Prevention (CDC) issued revised recommendations advocating voluntary human immunodeficiency virus (HIV) screening for all patients aged 13 to 64 years as Irosustat a normal part of medical practice in health-care settings including hospitals, acute-care clinics, and sexually transmitted disease (STD) clinics, unless the prevalence of undiagnosed HIV infection has been documented to be less than 0.1%.1This policy contrasted with previous recommendations for routine counseling and testing for people at high risk for HIV and for those in acute-care settings in which HIV prevalence was greater than 1%.2,3The earlier policy involved the provision of counseling and testing after patients gave specific informed consent for an HIV test. An estimated 25% of people infected with HIV are unaware they are infected.4The goals of the new CDC recommendations are to increase the number of people aware of their infection through routine testing and to link them with appropriate care and treatment.5Testing based on risk assessment often fails to identify many infected people.6Also, people aware of their infection are likely to change their behaviors and reduce the risk of infecting others.7Because extensive pretest prevention counseling and written informed consent specifically for an HIV test sometimes posed barriers to testing, a streamlined testing strategy was Irosustat recommended. With this approach, individuals are educated that an HIV test will become performed unless they decrease, and information about HIV illness is definitely often offered in writing. Consent for HIV screening is included in the general educated consent for medical care. Concurrently, HIV screening has increasingly used rapid tests that provide test results during the same health-care check out.8,9Compared with standard testing with an enzyme immunoassay (EIA), quick tests increase (by a factor of 1 1.5 to 2.2) the likelihood that both HIV-infected and uninfected individuals receive their test results, because the results are delivered during the initial check out.10However, rapid checks typically cost more to perform than conventional checks. The purpose of this study was to estimate the costs of standard and quick HIV screening in three scenarios to illustrate the variations among screening strategies and systems. This short article presents fresh estimations of the costs of the conventional and quick screening methods in these different scenarios. Earlier economic analyses of quick HIV tests used a test that is Irosustat more challenging to perform and no longer on the market.11,12The current study also estimates the cost per HIV-infected patient correctly notified of his/her test result. This cost estimate adjusts the initial costs for the likelihood of individuals participating in the process and returning for and receiving correct test results. The settings analyzed with this studySTD clinics and emergency departments (EDs)will also be relevant to the issue of increasing screening in minority areas, given the significant number of minority individuals receiving solutions in these settings and the proportion of minorities that are estimated to be infected with HIV but unaware of their status.6,1315During 20012005, black people accounted for 51.0% of newly diagnosed HIV infections, and the greatest proportion of cases (48.0% and 47.4%, respectively) were among people aged 25 to 34 and 35 to 44 years.16 == METHODS == Actual costs, not charges, were estimated from your provider perspective. Input variables, including costs and probabilities of.
